Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 24 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection Study presents an AI-guided approach to target cancer antigens HER2 Is Not a Predictive Biomarker of Benefit From Up-front Chemotherapy Plus Bevacizumab or Anti-EGFR, but Negative Prognostic Factor in pMMR/MSS RAS/BRAF Wild-Type mCRC MOST POPULAR FDA Approves Bosutinib for Paediatric Patients with Chronic Myelogenous Leukaemia October 13, 2023 How to Tell If Cancer Information on Social Media Is “Fake... September 29, 2020 Sparing the Hippocampus During PCI Better Preserves Cognitive Function in Patients... August 19, 2021 Junk food marketing restrictions: so near and yet so far December 15, 2022 Load more HOT NEWS Meet Rosalie: St. Jude Children’s Research Hospital’s New Service Dog For... Home Is Where the Heart Is John Travolta Supports Olivia Newton-John As She Battles Cancer ASCO20 Virtual Research Round Up Podcast: Breast Cancer, Sarcoma, and Supportive...
